Open Access

Table 3

Characteristics of metastatic pelvic sarcoma patients.

Age Clinical presentation Time to presentation Location Type Metastases location
  Pain Mass Constitutional symptoms Limping     Lung Bone marrow Bone
M, 10.3 Yes No Yes   2 months 1+2+4 Ewing Sarcoma Yes No No
M16.3 Yes No Yes   2 months 3 Ewing Sarcoma Yes No No
M, 6.9 Yes No No   2 weeks 5 Ewing Sarcoma Yes No No
F, 16.8 Yes No Yes   9 months 1 Ewing Sarcoma Yes No Yes
M, 12.9 Yes No Yes   1 month 4 Ewing Sarcoma No No Yes
F, 4.4 Yes No Yes   2 months 1+2 Ewing Sarcoma Yes Yes Yes
M, 17.8 Yes No No   7 months 1+2 Ewing Sarcoma Yes No No
M, 11.9 Yes No Yes   2 months 1 Ewing Sarcoma No Yes No
M, 12.5 Yes No No   5 months 3 Ewing Sarcoma Yes No Yes
F, 5.1 Yes No Yes   7 months 1 Ewing Sarcoma No No Yes
F, 9.9 Yes No No   1 week 3 Ewing Sarcoma Yes No No
M, 14.1 Yes No No   7 months 3 Ewing Sarcoma Yes No No
M, 12.4 Yes Yes No   3 months 1+2 Ewing Sarcoma Yes No No
F, 10.4 Yes No No   one month 3 Ewing Sarcoma Yes Yes Yes
M, 9.9 Yes No No   > 6 months 2+3 Osteosarcoma Yes No No
M, 9.7 Yes No No Yes 5 months 1 Osteosarcoma Yes No No
M, 18.5 Yes No No   incidental 1+4 Osteosarcoma Yes Yes No
F, 12.3 Yes No Yes   6 months 2+3+4 Osteosarcoma No No Yes
M, 3.9 Yes   No Yes 1 month 1 Osteosarcoma Yes No Yes
M, 15.2 Yes No No   2-3 months 1 Osteosarcoma No No Yes
M, 4.6 No Yes No   3 years Pelvic mass Synovial cell sarcoma Yes No No

Location was stratified based on Enneking classification.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.